🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Colgate-Palmolive Company CL SPXR3K

Consumer Defensive · Household & Personal Products · United States
https://www.colgatepalmolive.com
Company Profile ↓
$88.77
+5.39% 1Y
Mkt Cap$70.77B
P/E34.95
P/B315.10
Div. Yield2.28%
52W High$97.97
52W Low$73.64
Book Value$0.30
EPS (TTM)$2.54

Company Overview

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Why Investors Should Care

Healthy Capital Returns

Return on capital employed stands at 34.9%.

Healthy Margins

Operating margin of 21.0% supports profitability.

Dividend Income

Offers a dividend yield of 2.28%.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $20.38B (+1.4% YoY); net profit $2.13B.
  • Trailing 12 Months Year-on-year growth — revenue +4.9%, earnings -5.5%.
  • 5-Year Trend Long-term compounding — revenue CAGR 2.2%, profit CAGR 1.1%.

Growth & Price Performance

Compounded Sales Growth

5 Years:2.19%
1 Year:4.90%

Compounded Profit Growth

5 Years:1.14%
1 Year:-5.50%

Stock Price Performance

1 Year:+5.39%
6 Months:-3.98%
3 Months:+0.79%
1 Month:-4.55%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 62% of range
$73.64 $97.97
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMAAbove
  • RSI (14)40.30 · Neutral
Price Performance
1M-4.55%
3M+0.79%
6M-3.98%
1Y+5.39%
Valuation vs Sector

P/E of 34.95 is above the sector median of 18.74 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Healthy ROCE of 34.9%.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
34.95
Industry PE
18.74
Forward P/E
21.65
PEG Ratio
1.79
Book Value
$0.30
Price to Book
315.10
P/S
3.53
EV/EBITDA
16.27
Dividend Yield
2.28%

Growth (CAGR)

Revenue 5Y
2.19%
Profit 5Y
1.14%
Revenue (YoY)
4.90%
Earnings (YoY)
-5.50%

Profitability & Returns

ROCE
34.88%
ROE
-
ROA
15.84%
Profit Margin
9.68%
Op Margin
20.97%
Gross Margin
60.43%
EPS (Latest Qtr)
$0.86
EPS (TTM)
$2.54

Balance Sheet & Liquidity

Debt/Equity
13.88
Quick Ratio
0.56
Current Ratio
1.03
Debt
$7.86B
Total Assets
$16.79B
Current Assets
$5.71B
Working Capital
$-1.14B

Ownership

Promoter Holding
0.15%
Chg in Prom Hold
0.00%
FII / Inst Holding
86.66%
Chg in FII Hold
-0.01%

Financial Snapshot

Enterprise Value
$70.77B
Total Revenue (TTM)
$21.05B
EBITDA
$4.98B
Free Cash Flow
$3.46B
Operating Cash Flow
$4.46B
Shares Outstanding
797.17M
Gross Margin
60.43%
Payout Ratio
82.28%

Peer comparison

Peer companies in the same sector (Consumer Defensive).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 CL Colgate-Palmolive Company SPXR3K 88.77 34.95 $70.77B 2.28% 34.88% - 2.19% 1.14%
2 WMT Walmart Inc. SPXR3K 107.14 37.73 $852.63B 0.88% 16.83% 24.13% 3.82% 3.24%
3 COST Costco Wholesale Corporation NDXSPXR3K 915.74 46.16 $406.11B 0.62% 25.96% 29.15% 8.16% 11.45%
4 KO The Coca-Cola Company SPXR3K 88.07 26.45 $378.93B 2.44% 16.47% 42.05% 2.86% 4.46%
5 PG The Procter & Gamble Company SPXR3K 146.44 22.32 $341.00B 2.96% 22.49% 30.29% 0.52% 1.59%
6 PM Philip Morris International Inc. SPXR3K 182.53 25.07 $284.49B 3.13% 34.03% -113.55% -1.69% 3.57%
7 PEP PepsiCo, Inc. NDXSPXR3K 137.63 18.04 $188.00B 4.28% 15.41% 51.51% 4.93% 2.11%
8 BUD Anheuser-Busch InBev SA/NV 80.35 17.32 $140.40B 1.61% 8.49% 11.39% 0.88% 4.63%
9 MO Altria Group, Inc. SPXR3K 68.88 14.50 $115.01B 6.26% 38.27% - 1.24% -1.89%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue ------3.76B3.83B3.97B3.89B4.00B3.89B3.85B3.81B3.88B3.87B3.93B4.01B4.10B3.90B4.15B4.32B4.34B4.26B4.41B4.40B4.48B4.46B4.77B4.82B4.92B5.07B5.06B5.03B-5.11B5.13B5.23B5.32B5.36B
Cost of Revenue -----------------------------------2.04B2.08B2.08B2.10B2.06B
Gross Profit 2.35B2.29B2.25B2.30B2.32B2.25B2.27B2.30B2.38B2.33B2.41B2.30B2.27B2.25B2.29B2.31B2.32B2.41B2.46B2.37B2.54B2.64B2.64B2.56B2.62B2.57B2.55B2.55B2.71B2.79B2.88B3.04B3.07B3.07B-3.07B3.05B3.15B3.23B3.30B
Operating Expenses -----------------------------------1.99B1.99B2.13B2.26B2.28B
Operating Income 1.14B-867.00M944.00M1.07B-912.00M878.00M957.00M-983.00M946.00M874.00M-879.00M888.00M856.00M-952.00M946.00M1.02B-1.00B996.00M967.00M860.00M884.00M947.00M909.00M974.00M1.03B1.05B1.09B1.06B-1.08B1.06B1.02B964.00M1.02B
EBITDA -----------------------------------1.23B1.22B345.00M1.11B1.17B
Interest Expense -----------------------------------71.00M67.00M64.00M62.00M62.00M
Pretax Income -----------------------------------1.01B992.00M108.00M892.00M950.00M
Tax Provision -----------------------------------234.00M226.00M113.00M211.00M231.00M
Net Income 726.00M-458.00M533.00M600.00M702.00M606.00M570.00M524.00M607.00M323.00M634.00M637.00M523.00M606.00M560.00M586.00M578.00M643.00M715.00M635.00M698.00M647.00M681.00M703.00M634.00M559.00M603.00M618.00M372.00M502.00M708.00M683.00M731.00M737.00M-743.00M735.00M-37.00M646.00M693.00M
Diluted EPS 0.80-0.510.590.670.780.680.640.590.680.370.720.730.600.700.650.680.670.750.830.740.810.750.800.830.750.660.720.740.450.600.860.830.890.90-0.910.91-0.050.800.86

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 13.79B15.33B15.33B15.56B16.73B17.09B17.42B17.28B16.03B15.20B15.45B15.54B15.69B16.47B17.42B17.97B19.46B20.10B20.38B
Gross Profit 7.75B8.63B9.01B9.20B9.59B9.93B10.20B10.11B9.40B9.12B9.28B9.23B9.32B10.02B10.38B10.25B11.33B12.16B12.25B
Operating Income 2.72B3.10B3.62B3.49B3.84B3.89B3.56B3.56B2.79B3.96B3.71B3.69B3.55B3.88B3.33B2.89B3.98B4.27B3.31B
Net Income 1.74B1.96B2.29B2.20B2.43B2.47B2.24B2.18B1.38B2.44B2.02B2.40B2.37B2.69B2.17B1.78B2.30B2.89B2.13B
Diluted EPS 3.203.664.374.312.472.572.382.361.522.722.282.752.753.142.552.132.773.512.63
R&D Expense -240.00M256.00M256.00M262.00M259.00M267.00M277.00M274.00M289.00M285.00M277.00M281.00M290.00M307.00M320.00M343.00M355.00M366.00M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --9.98B11.13B11.17B12.72B13.39B13.98B13.44B11.94B12.12B12.68B12.16B15.03B15.92B-15.73B16.39B16.05B16.33B
Current Assets ----------------5.11B5.28B5.32B5.71B
Cash & Equivalents 490.00M429.00M555.00M600.00M490.00M878.00M884.00M962.00M1.09B970.00M1.31B1.53B726.00M883.00M888.00M-775.00M966.00M1.10B1.29B
Inventory ----------------2.07B1.93B1.99B2.03B
Receivables ----------------1.50B1.59B1.52B1.68B
Total Liabilities --7.93B7.88B8.36B10.18B11.00B11.45B12.07B11.98B12.11B12.43B11.96B14.48B14.82B-14.93B15.44B15.50B15.96B
Current Liabilities --2.95B3.60B3.73B3.72B3.74B4.58B3.95B3.53B3.31B3.41B3.34B4.04B4.40B-4.00B4.74B5.76B6.85B
Long Term Debt ---3.15B2.81B4.43B4.93B4.75B5.64B6.25B6.52B6.57B6.35B7.33B7.33B-8.74B8.22B7.29B6.87B
Total Debt ----------------9.27B9.06B8.51B8.55B
Total Equity --1.92B3.12B2.67B2.38B2.19B2.31B1.15B-299.00M-243.00M-60.00M-102.00M117.00M743.00M-401.00M609.00M212.00M54.00M
Shares Outstanding ----------------1.47B1.47B1.47B1.47B

Cash Flows (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 2.25B2.30B3.28B3.21B2.90B3.20B3.20B3.30B2.95B3.14B3.05B3.06B3.13B3.72B3.33B2.56B3.75B4.11B4.20B
Investing Cash Flow -528.00M-613.00M-841.00M-658.00M-1.21B-865.00M-890.00M-859.00M-685.00M-499.00M-471.00M-1.17B-2.10B-779.00M-592.00M-1.60B-742.00M-534.00M-817.00M
Financing Cash Flow -1.80B-1.53B-2.27B-2.62B-1.24B-2.30B-2.14B-2.17B-2.28B-2.23B-2.45B-2.68B-870.00M-2.92B-2.77B-952.00M-2.79B-3.39B-3.26B
Capital Expenditure -----537.00M-565.00M-670.00M-757.00M-691.00M-593.00M-553.00M-436.00M-335.00M-409.00M-567.00M-696.00M---
Free Cash Flow ----2.36B2.63B2.53B2.54B2.26B2.55B2.50B2.62B2.80B3.31B2.76B1.86B---
Share Buybacks 1.27B1.07B1.06B2.02B1.81B1.94B1.52B1.53B1.55B1.33B1.40B1.24B1.20B1.48B1.32B1.31B1.13B1.74B1.21B

Ratios (Annual)

Figures in %.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % 56.2%56.3%58.8%59.1%57.3%58.1%58.6%58.5%58.6%60.0%60.0%59.4%59.4%60.8%59.6%57.0%58.2%60.5%60.1%
Operating Margin % 19.7%20.2%23.6%22.4%23.0%22.8%20.4%20.6%17.4%26.0%24.0%23.8%22.6%23.6%19.1%16.1%20.5%21.2%16.2%
Net Margin % 12.6%12.8%14.9%14.2%14.5%14.5%12.9%12.6%8.6%16.1%13.1%15.4%15.1%16.4%12.4%9.9%11.8%14.4%10.5%
ROE % -101.8%73.5%82.4%102.4%112.9%97.2%190.4%-462.9%-1,004.5%-3,373.3%-2,352.9%2,023.1%362.7%-445.1%377.7%1,362.7%3,948.1%
ROCE % -44.1%48.0%46.9%42.6%40.3%37.8%37.5%33.2%44.9%40.0%41.9%32.3%33.7%-24.7%34.2%41.5%34.9%

Shareholding Pattern

Insiders
0.15%
Institutions
86.66%
Public Float
86.79%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 8.77% 69.92M $6.34B
2 Vanguard Capital Management LLC 6.55% 52.25M $4.74B
3 State Street Corporation 5.90% 47.02M $4.27B
4 Price (T.Rowe) Associates Inc 3.50% 27.91M $2.53B
5 Vanguard Portfolio Management LLC 3.01% 24.02M $2.18B
6 Geode Capital Management, LLC 2.90% 23.14M $2.10B
7 Morgan Stanley 2.77% 22.07M $2.00B
8 Bank Of New York Mellon Corporation 1.70% 13.53M $1.23B
9 Deutsche Bank AG 1.47% 11.75M $1.07B
10 NORGES BANK 1.22% 9.69M $879.01M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for CL

Google News Wed, 02 Sep 2026

Colgate-Palmolive (CL) Draws Fresh Valuation Focus, Is The Stock Fully Priced? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOdFdIVVpZcXJsb2Vzclc3X2xISXZGT1hFUV9XdVlEdzlkZGstOUJ1aDlTR0JZdUF1ZUg3ay1DNXNhZGVMOTJTRkhJVjlUSVhjVS1aQWdjX1VkOTliVEZlNG5jeDRiekVJYng0XzFfS2xtLWlLWG5RRmtPRzdwMXYta1d3a3VZbGNfVG9WeV…

Google News Mon, 07 Sep 2026

Colgate-Palmolive Company $CL Shares Purchased by First Eagle Investment Management LLC - marketbeat.com

<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxOYzNuZHczMnZuU21WajYtY1Q5WlQzQW5oM0R1NDNGa3ZXeHd0YW9hSTdXbjlhYWRkdlg0U0dlYzBoTFNjV1p4eDlsT3o2YjV5R2I4MG1UN1VvSVE1cmZSUjZfWTQxTnVHaERJRGRTWmlrZ2g0LTI5VllOVHVVMTRDc2hUNjltSmxPSGlDTX…

Google News Fri, 04 Sep 2026

Colgate-Palmolive Stock: Is CL Outperforming the Consumer Defensive Sector? - Barchart.com

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxOUGtwUVRlVDRJY1UzcUdUTGdVMFV2WTdOWEhHeVNVZUdvU01FZjdxdDF3aHV6eDAtUThOVHpfNHdUd1ZQMlVKS2s3WEpkcXlfXzdnb1p6VFBuMzBFek04dnV1cWZNbWJMNEV4QXNaeDFlaE5TUFotWFRjbGdnS2hSRGp4aTMzTzg4T2xDNz…

Google News hu, 03 Sep 2026

Brown-Forman Corp. Cl B stock outperforms competitors on strong trading day - MarketWatch

<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxNM0dwZC1tZWdSYkRiZV9Ga1VWMWp3bUNKakxEVExHMGk4ZjhROG9iR0RudFZGWjhNeEJGRTFzVUJ5STJCbk1tNDNubDRGYW52MjlQZXRYaW94WHY5djRlUVZ3V0hxWDl3RlkzS191TnZkNDNlZjVOek41dkpleXU2b01jSm1iUUZqV0h3Um…

Google News hu, 03 Sep 2026

Is Colgate-Palmolive (CL) Expensive As Investors Weigh Its Premium P/E And Fair Value Gap? - simplywall.st

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxQUGFTSU8zS1UtOEU5c1haaXZHdllZR3MtdWxZaXQ0c1Z0NTFMQm9BWTJSWEJmeThOXy1yWFAzWElVb1lVdk5kMEdHcEh4NnI4c0xjTldYeXJSMTV1cV90R2Vnb054UFNNMGtUQUdGa1ZxaHdNM2Q3eHlmc3dTWjFMRGx1RnJCdnVSTUhZSE…

Google News Wed, 02 Sep 2026

Colgate-Palmolive: Don’t Ignore This Resilient Dividend King (NYSE:CL) - Seeking Alpha

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQb0FNNnVuY01Tbmtqc0pIZ250X181RU1GS0h0QS15dEhLT1M4UEstLXI4eDdZa3NOZlBZTW9KdzdHZGpwd0NuUVJScmx2WWVwNmhZanY0WFo1M1oySHFxNFlOMEhWb1BmOTB6NnZpa2V4OXFjcm1xN3lYZUdkRWNCbE9Kd0VJaGZHd1EwYW…

CL — Frequently Asked Questions

What is the current share price of Colgate-Palmolive Company (CL)?

As of 2026-09-07 16:24 PDT, Colgate-Palmolive Company (CL) trades at $88.77 on NYSE. Its 52-week range is $73.64 to $97.97.

What is the market capitalisation of CL?

Colgate-Palmolive Company (CL) has a market capitalisation of $70.77B on NYSE.

What is the P/E ratio of CL?

CL trades at a trailing price-to-earnings (P/E) ratio of 34.95. The industry average P/E is 18.74. Its price-to-book (P/B) ratio is 315.10.

Does CL pay a dividend?

Colgate-Palmolive Company (CL) currently offers a dividend yield of 2.28%.

Is CL a good stock to buy?

This page provides a data-driven analysis of Colgate-Palmolive Company (CL), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Consumer Defensive Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space